Please provide your email address to receive an email when new articles are posted on . Historically, patient-reported outcome measures were primarily used for research. Today, surgeons use ...

The Adapt Oculus trial is unique in that it includes a patient population often overlooked in clinical trials, patients ...

Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B with inhibitors. Among individuals with ...

Patient-reported outcome measures improve survival risk and quality of life for cancer patients, according to a study published Aug. 13 in JAMA Network Open. PROMs are self-reported statements from ...

Adjuvant therapy with Imfinzi (durvalumab) and Imjudo (tremelimumab-actl) in patients with resected renal cell carcinoma was ...

There is a lack of systematic solutions to manage supportive care issues in racial/ethnic minorities (REM) receiving treatment for cancer. We developed and implemented an electronic patient-reported ...

GP empathy assessed using the Consultation and Relational Empathy (CARE) Measure was correlated with improved patient enablement, greater satisfaction, and improvement in symptoms in telephone ...

Of the phase III trials that planned to report QoL outcomes, nearly 40% never did ...

SAN DIEGO, June 2, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data from the Phase 4 KINECT-PROTM open-label study demonstrating robust and sustained ...

Abrocitinib shows sustained improvement in atopic dermatitis symptoms over two years with an acceptable safety profile.

April 10 meeting in Charlotte, NC, co-located with HMP Global’s SAWC Spring | WHS, advances regulatory science and ...